GlassScriptPhysician profile
Pablo Zeballos
NPI 1033301981
$3,123.17
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,282 · 2020: $808 · 2021: $19.57 · 2022: $14.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $876.32 | 2019-2020 | |
| Boston Scientific Corporation | $318.14 | 2019-2020 | |
| Spr Therapeutics, INC | $298.89 | 2019 | |
| Nevro Corp. | $277.60 | 2019 | |
| Collegium Pharmaceutical, INC. | $258.26 | 2019-2020 | |
| Assertio Therapeutics, INC. | $247.38 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $121.26 | 2019-2020 | |
| Allergan, INC. | $114.17 | 2019-2021 | |
| Vertos Medical, INC. | $111.10 | 2019-2020 | |
| Forte Bio-Pharma LLC | $103.09 | 2019-2020 | |
| Medtronic USA, INC. | $70.20 | 2019-2020 | |
| Pacira Therapeutics, INC. | $52.88 | 2019-2020 | |
| Daiichi Sankyo INC. | $49.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $44.91 | 2019-2020 | |
| Ibsa Pharma INC. | $29.99 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $28.53 | 2019 | |
| Djo, LLC | $20.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.87 | 2019 | |
| Pfizer INC. | $18.75 | 2020 | |
| Epimed International, INC | $15.26 | 2019 | |
| Stryker Corporation | $11.93 | 2019 | |
| Horizon Therapeutics Plc | $11.56 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.49 | 2019 | |
| Arteriocyte Medical Systems, INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Zeballos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.